Shi Y, Wareham DW, Yuan Y, Deng X, Mata A and Azevedo HS (2021). Polymyxin B-Triggered Assembly of Peptide Hydrogels for Localized and Sustained Release of Combined Antimicrobial Therapy. Advanced Healthcare Materials  10.1002/adhm.202101465

Mabayoje DA, NicFhogartaigh C, Cherian BP, Tan MGM and Wareham DW (2021). Compassionate use of cefiderocol for carbapenem-resistant Acinetobacter baumannii prosthetic joint infection. Jac Antimicrob Resist  vol. 3, (Suppl 1) i21-i24. 10.1093/jacamr/dlab055

Montag D, Delgado CA, Quispe C, Wareham D, Gallo V, Sanchez-Choy J, Sánchez V, Anaya R, Flores E, Roca L, Mamani V, Rivera Medina J, Velasquez P, Del Aguila C, Prendergast A and Palomino J (2021). Launching of the Anaemia Research Peruvian Cohort (ARPEC): A multicentre birth cohort project to explore the iron adaptive homeostasis, infant growth and development in three Peruvian regions. Bmj Open  vol. 11, (5) 10.1136/bmjopen-2020-045609

Shi Y, Wareham DW, Phee LM and Azevedo HS (2021). CHAPTER 12: Self-assembled Peptide Nanostructures for Antibacterial Applications. Rsc Soft Matter  10.1039/9781839161148-00395

McCarthy RR, Larrouy-Maumus GJ, Meiqi Tan MGC and Wareham DW (2021). Antibiotic Resistance Mechanisms and Their Transmission in Acinetobacter baumannii. Advances in Experimental Medicine and Biology  10.1007/978-3-030-67452-6_7

Lampejo T, Cherian BP, Tan MGM and Wareham DW (2020). Cefiderocol in the treatment of systemic carbapenemase-producing multidrug-resistant Klebsiella pneumoniae infection. Journal of Global Antimicrobial Resistance  vol. 23, 338-339. 10.1016/j.jgar.2020.10.008

Bean DC, Wigmore SM, Abdul Momin MHF and Wareham DW (2020). Polymyxin Resistant Bacteria in Australian Poultry. Frontiers in Sustainable Food Systems  vol. 4, 10.3389/fsufs.2020.550318

Wareham DW, Momin MHFA, Phee LM, Hornsey M and Standing JF (2020). Cefepime/sulbactam as an enhanced antimicrobial combination therapy for the treatment of MDR Gram-negative infections—authors’ response. Journal of Antimicrobial Chemotherapy  vol. 75, (9) 10.1093/jac/dkaa270

Maslova E, Shi Y, Sjöberg F, Azevedo HS, Wareham DW and McCarthy RR (2020). An Invertebrate Burn Wound Model That Recapitulates the Hallmarks of Burn Trauma and Infection Seen in Mammalian Models. Frontiers Media Sa  Frontiers in Microbiology  vol. 11, 10.3389/fmicb.2020.00998

Wareham DW, Momin MHFA, Phee LM, Hornsey M and Standing JF (2020). Cefepime/sulbactam as an enhanced antimicrobial combination therapy for the treatment of MDR Gram-negative infections. Journal of Antimicrobial Chemotherapy  vol. 75, (1) 135-139. 10.1093/jac/dkz420

Day MJ, Hopkins KL, Wareham DW, Toleman MA, Elviss N, Randall L, Teale C, Cleary P, Wiuff C, Doumith M, Ellington MJ, Woodford N and Livermore DM (2019). Extended-spectrum β-lactamase-producing Escherichia coli in human-derived and foodchain-derived samples from England, Wales, and Scotland: an epidemiological surveillance and typing study. The Lancet Infectious Diseases  vol. 19, (12) 1325-1335. 10.1016/S1473-3099(19)30273-7

Abdul Momin MHF, Liakopoulos A, Bean DC, Phee LM and Wareham DW (2019). A novel plasmid-mediated polymyxin resistance determinant (mcr-1.8) in Escherichia coli recovered from broiler chickens in Brunei Darussalam. J Antimicrob Chemother  10.1093/jac/dkz352

Bean DC, Agarwal A, Cherian BP and Wareham DW (2019). Hypermucoviscous polymyxin-resistant Klebsiella pneumoniae from Kolkata, India: Genomic and phenotypic analysis. Journal of Global Antimicrobial Resistance  vol. 17, 1-2. 10.1016/j.jgar.2019.02.012

Phee LM, Kloprogge F, Morris R, Barrett J, Wareham DW and Standing JF (2019). Pharmacokinetic-pharmacodynamic modelling to investigate in vitro synergy between colistin and fusidic acid against MDR Acinetobacter baumannii. Journal of Antimicrobial Chemotherapy  vol. 74, (4) 961-969. 10.1093/jac/dky524

Livermore DM, Day M, Cleary P, Hopkins KL, Toleman MA, Wareham DW, Wiuff C, Doumith M and Woodford N (2019). OXA-1 β-lactamase and non-susceptibility to penicillin/β-lactamase inhibitor combinations among ESBL-producing Escherichia coli. Journal of Antimicrobial Chemotherapy  vol. 74, (2) 326-333. 10.1093/jac/dky453

Hornsey M, Betts JW, Mehat JW, Wareham DW, van Vliet AHM, Woodward MJ and La Ragione RM (2018). Characterization of a colistin-resistant Avian Pathogenic Escherichia coli ST69 isolate recovered from a broiler chicken in Germany. J Med Microbiol  vol. 68, (1) 111-114. 10.1099/jmm.0.000882

Wareham DW, Phee LM and Abdul Momin MHF (2018). Direct detection of carbapenem resistance determinants in clinical specimens using immunochromatographic lateral flow devices. J Antimicrob Chemother  vol. 73, (7) 1997-1998. 10.1093/jac/dky095

WAREHAM DW (2018). Effects of In vivo Emergent Tigecycline Resistance on the Pathogenic Potential of Acinetobacter baumannii. Nature Publishing Group  Scientific Reports  10.1038/s41598-018-22549-6

Ciesielczuk H, Phee LM, Dolphin H, Wilks M, Cherian BP and Wareham DW (2018). Optimal detection of carbapenemase-producing Enterobacteriaceae from rectal samples: a role for enrichment? Journal of Hospital Infection  vol. 98, (3) 270-274. 10.1016/j.jhin.2017.10.012

Woodford N, Xu-McCrae L, Mushtaq S, Wu HHT, Ellington MJ, Lancaster O, Davies F, Donaldson H, Gopal Rao G, Verma A, Wareham DW, Ciesielczuk H, Stone GG, Irani PM, Bracher S and Hawkey PM (2018). Prevalence of carbapenem resistance and carbapenemase production among Enterobacteriaceae isolated from urine in the UK: Results of the UK infection-Carbapenem Resistance Evaluation Surveillance Trial (iCREST-UK). Journal of Antimicrobial Chemotherapy  vol. 73, (3) 698-702. 10.1093/jac/dkx471

Betts JW, Abdul Momin HF, Phee LM and Wareham DW (2018). Comparative activity of tedizolid and glycopeptide combination therapies for the treatment of Staphylococcus aureus infections: an in vitro and in vivo evaluation against strains with reduced susceptibility to glycopeptides. J Med Microbiol  vol. 67, (2) 265-271. 10.1099/jmm.0.000671

Abdul Momin MHF, Bean DC, Hendriksen RS, Haenni M, Phee LM and Wareham DW (2017). CHROMagar COL-APSE: a selective bacterial culture medium for the isolation and differentiation of colistin-resistant Gram-negative pathogens. J Med Microbiol  vol. 66, (11) 1554-1561. 10.1099/jmm.0.000602

WAREHAM DW (2017). A Drug to Consider Re-purposing in the Targeted Treatment of Multi-drug Resistant Bacterial Infections? Journal of Laboratory and Precision Medicine  vol. 2, (49) 10.21037/jlpm.2017.06.18

Abdul Momin MHF, Liakopoulos A and Wareham DW (2017). Draft Genome Sequence of a Multidrug-Resistant Sequence Type 231 Outbreak-Associated Clone of Klebsiella pneumoniae, KP41-2015, Producing OXA-232 Carbapenemase. Genome Announc  vol. 5, (27) 10.1128/genomeA.00604-17

Tängdén T, Ramos Martín V, Felton TW, Nielsen EI, Marchand S, Brüggemann RJ, Bulitta JB, Bassetti M, Theuretzbacher U, Tsuji BT, Wareham DW, Friberg LE, De Waele JJ, Tam VH and Roberts JA (2017). The role of infection models and PK/PD modelling for optimising care of critically ill patients with severe infections. Intensive Care Medicine  vol. 43, (7) 1021-1032. 10.1007/s00134-017-4780-6

Betts JW, Hornsey M, Wareham DW and La Ragione RM (2017). In vitro and In vivo Activity of Theaflavin-Epicatechin Combinations versus Multidrug-Resistant Acinetobacter baumannii. Infect Dis Ther  10.1007/s40121-017-0161-2

Lüthje P, Pranada AB, Carruthers-Lay D, Desjardins M, Gaillot O, Wareham D, Ciesielczuk H and Özenci V (2017). Identification of microorganisms grown on chromogenic media by MALDI-TOF MS. Journal of Microbiological Methods  vol. 136, 17-20. 10.1016/j.mimet.2017.03.001

Abdul Momin MHF, Liakopoulos A, Phee LM and Wareham DW (2017). Emergence and nosocomial spread of carbapenem-resistant OXA-232-producing Klebsiella pneumoniae in Brunei Darussalam. Elsevier  J Glob Antimicrob Resist  vol. 9, 96-99. 10.1016/j.jgar.2017.02.008

Cahill ST, Cain R, Wang DY, Lohans CT, Wareham DW, Oswin HP, Mohammed J, Spencer J, Fishwick CWG, McDonough MA, Schofield CJ and Brema J (2017). Cyclic boronates inhibit all classes of β-lactamases. Antimicrobial Agents and Chemotherapy  vol. 61, (4) 10.1128/AAC.02260-16

Wareham DW and Abdul Momin MHF (2017). Rapid Detection of Carbapenemases in Enterobacteriaceae: Evaluation of the Resist-3 O.K.N. (OXA-48, KPC, NDM) Lateral Flow Multiplexed Assay. J Clin Microbiol  vol. 55, (4) 1223-1225. 10.1128/JCM.02471-16

Liakopoulos A, Oikonomou O and Wareham DW (2017). Draft Genome Sequence of Providencia stuartii PS71, a Multidrug-Resistant Strain Associated with Nosocomial Infections in Greece. Genome Announc  vol. 5, (12) 10.1128/genomeA.00056-17

WAREHAM DW (2017). Draft Genome Sequence of a Canine Isolate of Methicillin-Resistant Staphylococcus haemolyticus. American Society For Microbiology  Genome Announcements  10.1128/genomeA.00146-17

Bean DC, Wigmore SM and Wareham DW (2017). Draft Genome Sequence of Staphylococcus cohnii subsp. urealyticus Isolated from a Healthy Dog. Genome Announc  vol. 5, (7) 10.1128/genomeA.01628-16

Li G-B, Abboud MI, Brem J, Someya H, Lohans CT, Yang S-Y, Spencer J, Wareham DW, McDonough MA and Schofield CJ (2016). NMR-filtered virtual screening leads to non-metal chelating metallo-β-lactamase inhibitors. Chem Sci  vol. 8, (2) 928-937. 10.1039/c6sc04524c

Oikonomou O, Liakopoulos A, Phee LM, Betts J, Mevius D and Wareham DW (2016). Providencia stuartii Isolates from Greece: Co-Carriage of Cephalosporin ( bla SHV-5 , bla VEB-1 ), Carbapenem ( bla VIM-1 ), and Aminoglycoside ( rmtB ) Resistance Determinants by a Multidrug-Resistant Outbreak Clone. Microbial Drug Resistance  vol. 22, (5) 379-386. 10.1089/mdr.2015.0215

Betts JW, Sharili AS, La Ragione RM and Wareham DW (2016). In Vitro Antibacterial Activity of Curcumin–Polymyxin B Combinations against Multidrug-Resistant Bacteria Associated with Traumatic Wound Infections. Journal of Natural Products  vol. 79, (6) 1702-1706. 10.1021/acs.jnatprod.6b00286

Ciesielczuk H, Jenkins C, Chattaway M, Doumith M, Hope R, Woodford N and Wareham DW (2016). Trends in ExPEC serogroups in the UK and their significance. European Journal of Clinical Microbiology & Infectious Diseases  10.1007/s10096-016-2707-8

Martínez-Guitián M, Vázquez-Ucha JC, Odingo J, Parish T, Poza M, Waite RD, Bou G, Wareham DW and Beceiro A (2016). Synergy between Colistin and the Signal Peptidase Inhibitor MD3 Is Dependent on the Mechanism of Colistin Resistance in Acinetobacter baumannii. Antimicrobial Agents and Chemotherapy  vol. 60, (7) 4375-4379. 10.1128/AAC.00510-16

Millar MR, Seale J, Turton J, Wilks M, Costeloe K, Woodford N, Juszczak E, Whiley A, Panton N and Wareham DW (2016). ESBL-producing Enterobacteriaceae in 24 neonatal units and associated networks in the south of England: No clustering of ESBL-producing Escherichia coli in units or networks. Journal of Antimicrobial Chemotherapy  vol. 71, (5) 1174-1177. 10.1093/jac/dkv459

Betts JW, Phee LM and Wareham DW (2016). Rifaximin combined with polymyxins: A potential regimen for selective decontamination of multidrug-resistant bacteria in the digestive tract? Journal of Global Antimicrobial Resistance  vol. 4, 11-15. 10.1016/j.jgar.2015.11.008

Wareham DW, Shah R, Betts JW, Phee LM and Momin MHFA (2016). Evaluation of an immunochromatographic lateral flow assay (OXA-48 K-SeT) for rapid detection of OXA-48-Like Carbapenemases in Enterobacteriaceae. Journal of Clinical Microbiology  vol. 54, (2) 471-473. 10.1128/JCM.02900-15

Betts JW, Phee LM, Abdul Momin MHF, Umland KD, Brem J, Schofield CJ and Wareham DW (2016). In vitro and in vivo activity of ML302F: A thioenolate inhibitor of VIM-subfamily metallo β-lactamases. Medchemcomm  vol. 7, (1) 190-193. 10.1039/c5md00380f

Ciesielczuk H, Doumith M, Hope R, Woodford N and Wareham DW (2015). Characterization of the extra-intestinal pathogenic Escherichia coli ST131 clone among isolates recovered from urinary and bloodstream infections in the United Kingdom. Journal of Medical Microbiology  vol. 64, (12) 1496-1503. 10.1099/jmm.0.000179

Betts JW, Sharili AS, Phee LM and Wareham DW (2015). In Vitro Activity of Epigallocatechin Gallate and Quercetin Alone and in Combination versus Clinical Isolates of Methicillin-Resistant Staphylococcus aureus. Journal of Natural Products  vol. 78, (8) 2145-2148. 10.1021/acs.jnatprod.5b00471

WAREHAM DW, Phee LM and Betts JW (2015). Colistin and Fusidic acid: A Novel Potent Synergistic Combination for the Treatment of Acinetobacter baumannii Infection. 10.1128/AAC.00753-15

Ciesielczuk H, Betts J, Phee L, Doumith M, Hope R, Woodford N and Wareham DW (2015). Comparative virulence of urinary and bloodstream isolates of extra-intestinal pathogenic Escherichia coli in a Galleria mellonella model. Virulence  vol. 6, (2) 145-151. 10.4161/21505594.2014.988095

Niebel M, Quick J, Prieto AMG, Hill RLR, Pike R, Huber D, David M, Hornsey M, Wareham D, Oppenheim B, Woodford N, Van Schaik W and Loman N (2015). Deletions in a ribosomal protein-coding gene are associated with tigecycline resistance in Enterococcus faecium. International Journal of Antimicrobial Agents  vol. 46, (5) 572-575. 10.1016/j.ijantimicag.2015.07.009

Makena A, Brem J, Pfeffer I, Geffen REJ, Wilkins SE, Tarhonskaya H, Flashman E, Phee LM, Wareham DW and Schofield CJ (2015). Biochemical characterization of New Delhi metallo-β-lactamase variants reveals differences in protein stability. J Antimicrob Chemother  vol. 70, (2) 463-469. 10.1093/jac/dku403

Personne Y, Curtis MA, Wareham DW and Waite RD (2014). Activity of the type I signal peptidase inhibitor MD3 against multidrug-resistant Gram-negative bacteria alone and in combination with colistin. J Antimicrob Chemother  vol. 69, (12) 3236-3243. 10.1093/jac/dku309

Phee L, Bharathan B and Wareham DW (2014). 481Successful Treatment of Multi-drug Resistant Acinetobacter baumannii Ventilator-Associated Pneumonia with a Novel Colistin and Fusidic Acid Combination Therapy. Open Forum Infectious Diseases  vol. 1, (suppl_1) s179-s179. 10.1093/ofid/ofu052.347

Betts JW, Phee LM, Woodford N and Wareham DW (2014). Activity of colistin in combination with tigecycline or rifampicin against multidrug-resistant Stenotrophomonas maltophilia. Eur J Clin Microbiol Infect Dis  vol. 33, (9) 1565-1572. 10.1007/s10096-014-2101-3

Betts JW and Wareham DW (2014). In vitro activity of curcumin in combination with epigallocatechin gallate (EGCG) versus multidrug-resistant Acinetobacter baumannii. Bmc Microbiol  vol. 14, 10.1186/1471-2180-14-172

Betts JW, Phee LM, Hornsey M, Woodford N and Wareham DW (2014). In vitro and in vivo activities of tigecycline-colistin combination therapies against carbapenem-resistant Enterobacteriaceae. Antimicrob Agents Chemother  vol. 58, (6) 3541-3546. 10.1128/AAC.02449-14

Cheng F, Betts JW, Kelly SM, Wareham DW, Kornherr A, Dumestre F, Schaller J and Heinze T (2014). Whiter, brighter, and more stable cellulose paper coated with antibacterial carboxymethyl starch stabilized ZnO nanoparticles. Journal of Materials Chemistry B  vol. 2, (20) 3057-3064. 10.1039/c3tb21734e

Cheng F, BETTS JW, Kelly SM, Wareham DW, Kornherr A, Dumestre F, Schaller J and Heinze T (2014). Whiter, brighter, and more stable cellulose paper coated with antibacterial carboxymethyl starch stabilized ZnO nanoparticles., Editors: McKenzie F. Royal  Journals of Materials Chemistry B: Materials For Biology and Medicine  vol. 2, 3057-3064. 10.1039/C4TB00548A

Woodford N, Wareham DW, Guerra B and Teale C (2014). Carbapenemase-producing enterobacteriaceae and non-enterobacteriaceae from animals and the environment: An emerging public health risk of our own making? Journal of Antimicrobial Chemotherapy  vol. 69, (2) 287-291. 10.1093/jac/dkt392

Ciesielczuk H, Hornsey M, Choi V, Woodford N and Wareham DW (2013). Development and evaluation of a multiplex PCR for eight plasmid-mediated quinolone-resistance determinants. J Med Microbiol  vol. 62, (Pt 12) 1823-1827. 10.1099/jmm.0.064428-0

Ciesielczuk H, Hornsey M, Choi V, Woodford N and Wareham DW (2013). Development and evaluation of a multiplex PCR for eight plasmid-mediated quinolone-resistance determinants. Journal of Medical Microbiology  vol. 62, (PART 12) 1823-1827. 10.1099/jmm.0.064428-0

Phee L, Hornsey M and Wareham DW (2013). In vitro activity of daptomycin in combination with low-dose colistin against a diverse collection of Gram-negative bacterial pathogens. Eur J Clin Microbiol Infect Dis  vol. 32, (10) 1291-1294. 10.1007/s10096-013-1875-z

Hornsey M, Phee L, Stubbings W and Wareham DW (2013). In vitro activity of the novel monosulfactam BAL30072 alone and in combination with meropenem versus a diverse collection of important Gram-negative pathogens. International Journal of Antimicrobial Agents  vol. 42, (4) 343-346. 10.1016/j.ijantimicag.2013.05.010

Phee L, Hornsey M and Wareham DW (2013). In vitro activity of daptomycin in combination with low-dose colistin against a diverse collection of Gram-negative bacterial pathogens. European Journal of Clinical Microbiology and Infectious Diseases  vol. 32, (10) 1291-1294. 10.1007/s10096-013-1875-z

Betts JW, Wareham DW, Haswell SJ and Kelly SM (2013). Antifungal synergy of theaflavin and epicatechin combinations against Candida albicans. J Microbiol Biotechnol  vol. 23, (9) 1322-1326. 10.4014/jmb.1303.03010

Wareham D, Phee L and Hornsey M (2013). P317 Isolation and characterisation of a novel Nesterenkonia species from a human bloodstream infection. International Journal of Antimicrobial Agents  vol. 42, s141-s142. 10.1016/s0924-8579(13)70558-2

Hornsey M, Phee L, Woodford N, Turton J, Meunier D, Thomas C and Wareham DW (2013). Evaluation of three selective chromogenic media, CHROMagar ESBL, CHROMagar CTX-M and CHROMagar KPC, for the detection of Klebsiella pneumoniae producing OXA-48 carbapenemase. J Clin Pathol  vol. 66, (4) 348-350. 10.1136/jclinpath-2012-201234

Hornsey M, Phee L, Woodford N, Turton J, Meunier D, Thomas C and Wareham DW (2013). Evaluation of three selective chromogenic media, CHROMagar ESBL, CHROMagar CTX-M and CHROMagar KPC, for the detection of Klebsiella pneumoniae producing OXA-48 carbapenemase. Journal of Clinical Pathology  vol. 66, (4) 348-350. 10.1136/jclinpath-2012-201234

Hornsey M, Phee L, Longshaw C and Wareham DW (2013). In vivo efficacy of telavancin/colistin combination therapy in a Galleria mellonella model of Acinetobacter baumannii infection. Int J Antimicrob Agents  vol. 41, (3) 285-287. 10.1016/j.ijantimicag.2012.11.013

Hornsey M, Phee L, Longshaw C and Wareham DW (2013). In vivo efficacy of telavancin/colistin combination therapy in a Galleria mellonella model of Acinetobacter baumannii infection. International Journal of Antimicrobial Agents  vol. 41, (3) 285-287. 10.1016/j.ijantimicag.2012.11.013

Hornsey M, Phee L, Stubbings W and Wareham DW (2013). In vitro activity of the novel monosulfactam BAL30072 alone and in combination with meropenem versus a diverse collection of important Gram-negative pathogens. International Journal of Antimicrobial Agents  10.1016/j.ijantimicag.2013.05.010

Baillie S, Ireland K, Warwick S, Wareham D and Wilks M (2013). Matrix-assisted laser desorption/ionisation-time of flight mass spectrometry: rapid identification of bacteria isolated from patients with cystic fibrosis. Br J Biomed Sci  vol. 70, (4) 144-148. 10.1080/09674845.2013.11669948

Hidalgo L, Hopkins KL, Wareham DW, Gutierrez B and Gonzalez-Zorn B (2012). Association of Extended-Spectrum beta-Lactamase VEB-5 and 16S rRNA Methyltransferase ArmA in Salmonella enterica from the United Kingdom. Antimicrobial Agents and Chemotherapy  vol. 56, (9) 4985-4987. 10.1128/AAC.00381-12

Hornsey M, Longshaw C, Phee L and Wareham DW (2012). In vitro activity of telavancin in combination with colistin versus Gram-negative bacterial pathogens. Antimicrob Agents Chemother  vol. 56, (6) 3080-3085. 10.1128/AAC.05870-11

Waite RD, Wareham DW, Gardiner S and Whiley RA (2012). A simple, semiselective medium for anaerobic isolation of anginosus group streptococci from patients with chronic lung disease. Journal of Clinical Microbiology  vol. 50, (4) 1430-1432. 10.1128/JCM.06184-11

Hornsey M, Phee L and Wareham DW (2011). A novel variant, NDM-5, of the New Delhi metallo-β-lactamase in a multidrug-resistant Escherichia coli ST648 isolate recovered from a patient in the United Kingdom. Antimicrob Agents Chemother  vol. 55, (12) 5952-5954. 10.1128/AAC.05108-11

Shah A and Wareham D (2011). EVALUATION OF RAPID E TEST MIC TESTING USING CHROM AGAR ON LOWER RESPIRATORY TRACT SAMPLES; COLLECTED FROM ICU FROM PATIENTS WITH SUSPECTED VENTILATOR ASSOCIATED PNEUMONIACATEGORY: LESSON IN MICROBIOLOGY & INFECTION CONTROL. Journal of Infection  vol. 63, (6) E22-E23. 10.1016/j.jinf.2011.04.051

Hornsey M and Wareham DW (2011). In vivo efficacy of glycopeptide-colistin combination therapies in a Galleria mellonella model of Acinetobacter baumannii infection. Antimicrob Agents Chemother  vol. 55, (7) 3534-3537. 10.1128/AAC.00230-11

Hornsey M, Loman N, Wareham DW, Ellington MJ, Pallen MJ, Turton JF, Underwood A, Gaulton T, Thomas CP, Doumith M, Livermore DM and Woodford N (2011). Whole-genome comparison of two Acinetobacter baumannii isolates from a single patient, where resistance developed during tigecycline therapy. J Antimicrob Chemother  vol. 66, (7) 1499-1503. 10.1093/jac/dkr168

Reddy S, Rangaiah J, Addiman S, Wareham D, Wilson P and Sefton A (2011). Epidemiology, antibiotic resistance trends and the cost of enteric fever in East London, 2005-2010. Travel Med Infect Dis  vol. 9, (4) 206-212. 10.1016/j.tmaid.2011.03.003

Wareham DW, Gordon NC and Hornsey M (2011). In vitro activity of teicoplanin combined with colistin versus multidrug-resistant strains of Acinetobacter baumannii. J Antimicrob Chemother  vol. 66, (5) 1047-1051. 10.1093/jac/dkr069

Phee L, Gordon N, Hornsey M and Wareham D (2011). De-escalation of antimicrobial therapy in Gram-negative sepsis: easier said than done? Critical Care  vol. 15, (Suppl 1) p219-p219. 10.1186/cc9639

Wareham DW and Gordon NC (2011). Modifications to CHROMagar Acinetobacter for improved selective growth of multi-drug resistant Acinetobacter baumannii. J Clin Pathol  vol. 64, (2) 164-167. 10.1136/jcp.2010.083469

Soleimanian S, Gordon NC and Wareham DW (2011). Polymicrobial necrotizing fasciitis involving enterobacteria producing CTX-M-15 extended-spectrum β-lactamases. J Med Microbiol  vol. 60, (Pt 1) 135-137. 10.1099/jmm.0.021998-0

Wareham DW, Gordon NC and Shimizu K (2011). Two new variants of and creation of a repository for Stenotrophomonas maltophilia quinolone protection protein (Smqnr) genes. Int J Antimicrob Agents  vol. 37, (1) 89-90. 10.1016/j.ijantimicag.2010.10.002

Gordon NC, Png K and Wareham DW (2010). Potent synergy and sustained bactericidal activity of a vancomycin-colistin combination versus multidrug-resistant strains of Acinetobacter baumannii. Antimicrob Agents Chemother  vol. 54, (12) 5316-5322. 10.1128/AAC.00922-10

Wareham DW, Umoren I, Khanna P and Gordon NC (2010). Allele-specific polymerase chain reaction (PCR) for rapid detection of the aac(6')-Ib-cr quinolone resistance gene. Int J Antimicrob Agents  vol. 36, (5) 476-477. 10.1016/j.ijantimicag.2010.07.012

Gordon NC and Wareham DW (2010). Antimicrobial activity of the green tea polyphenol (-)-epigallocatechin-3-gallate (EGCG) against clinical isolates of Stenotrophomonas maltophilia. Int J Antimicrob Agents  vol. 36, (2) 129-131. 10.1016/j.ijantimicag.2010.03.025

Hornsey M, Ellington MJ, Doumith M, Thomas CP, Gordon NC, Wareham DW, Quinn J, Lolans K, Livermore DM and Woodford N (2010). AdeABC-mediated efflux and tigecycline MICs for epidemic clones of Acinetobacter baumannii. J Antimicrob Chemother  vol. 65, (8) 1589-1593. 10.1093/jac/dkq218

Hall TJ, Wren MW, Wareham DW, Jeanes A and Gant VA (2010). Effect of the dried residues of two hand gels on the survival of meticillin-resistant staphylococcus aureus and acinetobacter calcoaceticus-baumannii. Journal of Infection Prevention  vol. 11, (3) 70-72. 10.1177/1757177410365579

Gordon NC and Wareham DW (2010). Novel variants of the Smqnr family of quinolone resistance genes in clinical isolates of Stenotrophomonas maltophilia. J Antimicrob Chemother  vol. 65, (3) 483-489. 10.1093/jac/dkp476

Jozsef S, Wareham DW, Ratkai C, Aduse-Opoku J, Urban E and Elisabeth N (2010). Prevalence, nucleotide sequence and expression studies of two proteins of a 5.6 kb, Class III, Bacteroides plasmid frequently found in clinical isolates from European countries. Plasmid  vol. 63, (2) 86-97. 10.1016/j.plasmid.2009.12.002

Gordon NC and Wareham DW (2010). Multidrug-resistant Acinetobacter baumannii: mechanisms of virulence and resistance. Int J Antimicrob Agents  vol. 35, (3) 219-226. 10.1016/j.ijantimicag.2009.10.024

Wareham D and Bean D (2010). Molecular typing of multi-drug resistant Acinetobacter baumannii from London hospitals. Int J Infect Dis  vol. 14, E36-E36. 10.1016/j.ijid.2010.02.1566

Millar M and Wareham D (2010). Infections associated with implanted medical devices. Antibiotic and Chemotherapy: Expert Consult  10.1016/B978-0-7020-4064-1.00042-7

Amin AK and Wareham DW (2009). Plasmid-mediated quinolone resistance genes in Enterobacteriaceae isolates associated with community and nosocomial urinary tract infection in East London, UK. Int J Antimicrob Agents  vol. 34, (5) 490-491. 10.1016/j.ijantimicag.2009.01.003

Gordon NC and Wareham DW (2009). Failure of the MicroScan WalkAway system to detect heteroresistance to carbapenems in a patient with Enterobacter aerogenes bacteremia. J Clin Microbiol  vol. 47, (9) 3024-3025. 10.1128/JCM.01033-09

Gordon NC and Wareham DW (2009). Evaluation of CHROMagar Acinetobacter for detection of enteric carriage of multidrug-resistant Acinetobacter baumannii in samples from critically ill patients. J Clin Microbiol  vol. 47, (7) 2249-2251. 10.1128/JCM.00634-09

Wareham DW, Gordon NC, Casals JB and Bean DC (2009). Reduced susceptibility of multidrug-resistant Acinetobacter baumannii to tigecycline in combination with 1-(1-naphthylmethyl)-piperazine is not a pH-dependent phenomenon. J Antimicrob Chemoth  vol. 63, (5) 1075-1076. 10.1093/jac/dkp072

(2009). Prevention of an outbreak of nosocomial bloodstream infection associated with a new vascular access device by retraining of staff. J Hosp Infect  vol. 72, (1) 85-87. 10.1016/j.jhin.2009.01.017

Soleimanian S and Wareham DW (2009). Pancreatitis, Diarrhea, and Glycopeptide Dependence. Infectious Diseases in Clinical Practice  vol. 17, (3) 206-207. 10.1097/ipc.0b013e31818718fd

Gordon NC and Wareham DW (2009). A review of clinical and microbiological outcomes following treatment of infections involving multidrug-resistant Acinetobacter baumannii with tigecycline. J Antimicrob Chemother  vol. 63, (4) 775-780. 10.1093/jac/dkn555

Woodford N, Wareham DW and UK Antibacterial Antisense Study Group (2009). Tackling antibiotic resistance: a dose of common antisense? J Antimicrob Chemother  vol. 63, (2) 225-229. 10.1093/jac/dkn467

Bean DC and Wareham DW (2009). Paradoxical effect of 1-(1-naphthylmethyl)-piperazine on resistance to tetracyclines in multidrug-resistant Acinetobacter baumannii. J Antimicrob Chemother  vol. 63, (2) 349-352. 10.1093/jac/dkn493

Wareham DW, Bean DC, Khanna P, Hennessy EM, Krahe D, Ely A and Millar M (2008). Bloodstream infection due to Acinetobacter spp: epidemiology, risk factors and impact of multi-drug resistance. Eur J Clin Microbiol Infect Dis  vol. 27, (7) 607-612. 10.1007/s10096-008-0473-y

Bean DC, Krahe D and Wareham DW (2008). Antimicrobial resistance in community and nosocomial Escherichia coli urinary tract isolates, London 2005-2006. Ann Clin Microbiol Antimicrob  vol. 7, 10.1186/1476-0711-7-13

Khanna P, Doffman S, Griffiths L, Wareham D, Agrawal SG and Das S (2008). A case of febrile nelitropenia with a skin rash. J Infection  vol. 56, (4) 309-309. 10.1016/j.jinf.2008.01.040

Wareham D and Bean D (2007). Nebulised colistin for nosocomial Acinetobacter baumannii respiratory tract infection. Cochrane Database of Systematic Reviews  (4) 10.1002/14651858.CD006820

Edwards J, Patel G and Wareham DW (2007). Low concentrations of commercial alcohol hand rubs facilitate growth of and secretion of extracellular proteins by multidrug-resistant strains of Acinetobacter baumannii. J Med Microbiol  vol. 56, (Pt 12) 1595-1599. 10.1099/jmm.0.47442-0

Wareham DW and Curtis MA (2007). A genotypic and phenotypic comparison of type III secretion profiles of Pseudomonas aeruginosa cystic fibrosis and bacteremia isolates. Int J Med Microbiol  vol. 297, (4) 227-234. 10.1016/j.ijmm.2007.02.004

Wareham DW and Breuer J (2007). Herpes zoster. Bmj  vol. 334, (7605) 1211-1215. 10.1136/bmj.39206.571042.AE

Michael JS, Wareham DW, El-Karim A, Warwick S, Millar M and Das SS (2007). Evaluation of 16SrDNA PCR and sequencing for the diagnosis of infective endocarditis. Clin Res Cardiol  vol. 96, (6) 411-412.

Wareham DW, Michael JS, Warwick S, Whitlock P, Wood A and Das SS (2007). The dangers of dog bites. J Clin Pathol  vol. 60, (3) 328-329. 10.1136/jcp.2006.037671

Michael JS, Das SS and Wareham DW (2007). The Dangers of Dog Bites. Journal of Infection  vol. 54, (3) 10.1016/j.jinf.2006.10.012

Pumbwe L, Wareham DW, Aduse-Opoku J, Brazier JS and Wexler HM (2007). Genetic analysis of mechanisms of multidrug resistance in a clinical isolate of Bacteroides fragilis. Clin Microbiol Infect  vol. 13, (2) 183-189. 10.1111/j.1469-0691.2006.01620.x

Cepeda JA, Millar M, Sheridan EA, Warwick S, Raftery M, Bean DC and Wareham DW (2006). Listeriosis due to infection with a catalase-negative strain of Listeria monocytogenes. J Clin Microbiol  vol. 44, (5) 1917-1918. 10.1128/JCM.44.5.1917-1918.2006

Wareham DW and Bean DC (2006). In-vitro activity of polymyxin B in combination with imipenem, rifampicin and azithromycin versus multidrug resistant strains of Acinetobacter baumannii producing OXA-23 carbapenemases. Ann Clin Microbiol Antimicrob  vol. 5, 10.1186/1476-0711-5-10

Wareham DW, Abbas H, Karcher AM and Das SS (2006). Treatment of prosthetic valve infective endocarditis due to multi-resistant Gram-positive bacteria with linezolid. J Infect  vol. 52, (4) 300-304. 10.1016/j.jinf.2005.05.022

Wareham DW and Bean DC (2006). In vitro activities of polymyxin B, imipenem, and rifampin against multidrug-resistant Acinetobacter baumannii. Antimicrob Agents Chemother  vol. 50, (2) 10.1128/AAC.50.2.825-826.2006

Wareham D (2005). Postherpetic neuralgia. Clin Evid  (14) 1017-1025.

Wareham DW, Wilks M, Ahmed D, Brazier JS and Millar M (2005). Anaerobic sepsis due to multidrug-resistant Bacteroides fragilis: microbiological cure and clinical response with linezolid therapy. Clin Infect Dis  vol. 40, (7) e67-e68. 10.1086/428623

Wareham DW, Papakonstantinopoulou A and Curtis MA (2005). The Pseudomonas aeruginosa PA14 type III secretion system is expressed but not essential to virulence in the Caenorhabditis elegans-P. aeruginosa pathogenicity model. Fems Microbiol Lett  vol. 242, (2) 209-216. 10.1016/j.femsle.2004.11.018

WAREHAM DW, Das S and Michael J (2005). Advances in bacterial specific imaging. Brazilian Archives of Biology and Technology  vol. 48, 145-152. 10.1590/S1516-89132005000700021

WAREHAM DW, Das SS, Abbas H and Karcher AM (2005). Treatment of infective endocarditis due to multiresistant Gram-positive bacteria with linezolid. J Infect  10.1016/j.jinf.2005.05.022

Wareham D (2004). Postherpetic neuralgia. Clin Evid  (12) 1182-1193.

Wareham D (2003). Postherpetic neuralgia. Clin Evid  (10) 942-952.

Lancaster T, Wareham DW and Yaphe J (2003). Postherpetic neuralgia. Am Fam Physician  vol. 67, (7) 1557-1558.

Das SS, Britton KE, Solanki KK and Wareham DW (2003). (99m)Tc-ciprofloxacin scintigraphy in rabbit model of prosthetic joint infection. J Nucl Med  vol. 44, (2) 317-319.

Lancaster T, Wareham D and Yaphe J (2003). Postherpetic neuralgia. Clinical Evidence  (9) 890-900.

Britton KE, Wareham DW, Das SS, Solanki KK, Amaral H, Bhatnagar A, Katamihardja AHS, Malamitsi J, Moustafa HM, Soroa VE, Sundram FX and Padhy AK (2002). Imaging bacterial infection with (99m)Tc-ciprofloxacin (Infecton). J Clin Pathol  vol. 55, (11) 817-823. 10.1136/jcp.55.11.817

Das SS, Wareham DW and Britton KE (2002). 99mTc-labeled antimicrobial peptides for detection of bacterial and Candida albicans infections. J Nucl Med  vol. 43, (8)

Wareham DW and Wilson P (2002). Chloramphenicol in the 21st century. Hosp Med  vol. 63, (3) 157-161. 10.12968/hosp.2002.63.3.2061

BRITTON KE, Soroa VE, Das SS, Sundram FX, Padhy AK, Wareham DW, Solanki KK, Moustafa HM, Katamihardja AH, Bhatnagar A, Amaral H and Malamitsi J (2002). Imaging bacterial infection with (99m)Tc-Ciprofloxacin (Infecton). J Clin Pathol.  vol. 55, 817-823. 10.1136/jcp.55.11.817

Lancaster T, Wareham D and Yaphe J (2002). Postherpetic neuralgia. Clinical Evidence  (7) 738-746.

Wareham DW, Döring G and Vochem M (2001). Sepsis in a newborn due to Pseudomas aeruginosa from a contaminated tub bath [4] (multiple letters). New England Journal of Medicine  vol. 345, (22) 1644-1645. 10.1056/NEJM200111293452214

Wareham DW (2001). Sepsis in a newborn due to Pseudomonas aeruginosa from a contaminated tub bath. N Engl J Med  vol. 345, (22) 1644-1645. 10.1056/nejm200111293452215

Britton KE, Wareham DW and Das SS (2001). Concerns about 99mTc-labelled ciprofloxacin for infection detection. Eur J Nucl Med  vol. 28, (6) 779-781. 10.1007/s002590100520

Wareham DW, Breuer J, Healy MT and Goldhill DR (2001). Pneumonitis in an elderly Bangladeshi man. J Clin Pathol  vol. 54, (6) 10.1136/jcp.54.6.494

BRITTON KE, Das SS and Wareham DW (2001). Concerns about 99mTc-labelledCiprofloxacin for infection detection. Eur J Nucl Med.  vol. 28, 779-781. 10.1007/s002590100520

Breuer J and WAREHAM DW (2001). Primary varicella infection presenting in old age. Grand Rounds  vol. 1, 3-4.

Das SS, Britton KE, Solanki KK, Wareham DW, Pauwels EKJ, Welling MM, Lupetti A, Paulusma-Annema A, Nibbering PH and Balter HS (2000). Technetium-99m labelled antimicrobial peptides discriminate between bacterial infections and sterile inflammations (multiple letters). European Journal of Nuclear Medicine  vol. 27, (12) 1865-1868. 10.1007/s002590000378

Britton KE, Wareham D, Solanki KK and Das SS (2000). Imaging of bacterial infections with Tc-99m-labeled human neutrophil peptide-1. J Nucl Med  vol. 41, (12) 2099-2100.

Britton KE, Solanki KK, Das SS, Amaral H, Bhatnagar A, Katamihardja AH, Malamitsi J, Moustafa H, Soroa VE, Sundram FX, Wareham DW and Padhy AK (2000). Bacterial specific imaging. Journal of Nuclear Medicine  vol. 41, (5) 11P-11P.

Wareham DW and Breuer J (2000). Management of occupational exposure to hepatitis C: survey of United Kingdom practice. Communicable Disease and Public Health / Phls  vol. 3, (4) 295-296.